PURPOSE: In prosthetic joint infections (PJIs) of the knee, debridement with implant retention is associated with a high risk of recurrence. METHODS: A single-centre cohort study was performed with extensive analysis of the literature covering 1980-2012. RESULTS: In 21 patients (mean age 80.4 years, 19 immunosuppressed), in association with 1.5-three months of antibiotic treatment, an attempt was made to salvage the prosthesis by open (11 patients) or arthroscopic (ten patients) debridement. After a mean follow-up of seven years (range four-20 years), patients were in remission in seven cases (33 %). Remission was achieved in 0 % of all methicillin-resistant Staphylococcus aureus (MRSA) infections (zero/three), in 0 % (zero/three) of methicillin-resistant coagulase-negative staphylococcal infections, in 29 % (two/seven) of methicillin-sensitive S. aureus infections and in 75 % (three/four) of infections due to streptococci. The literature review focused on implant preserving approaches yielded 599 cases with an overall success rate of 47 % (284/599) and significantly more remissions in streptococcal vs staphylococcal knee PJIs (43/54 vs 144/324; p < 0.01, odds ratio 4.9, 95 % confidence interval 2.4-10.9). CONCLUSIONS: In addition to established indications for explantation such as implant loosening, sinus tract or methicillin resistance, the decision for debridement and retention of knee PJIs should also depend on the pathogen. Implant preservation is futile with methicillin-resistant staphylococci, but seems to be a valid option for streptococcal PJIs.
PURPOSE: In prosthetic joint infections (PJIs) of the knee, debridement with implant retention is associated with a high risk of recurrence. METHODS: A single-centre cohort study was performed with extensive analysis of the literature covering 1980-2012. RESULTS: In 21 patients (mean age 80.4 years, 19 immunosuppressed), in association with 1.5-three months of antibiotic treatment, an attempt was made to salvage the prosthesis by open (11 patients) or arthroscopic (ten patients) debridement. After a mean follow-up of seven years (range four-20 years), patients were in remission in seven cases (33 %). Remission was achieved in 0 % of all methicillin-resistant Staphylococcus aureus (MRSA) infections (zero/three), in 0 % (zero/three) of methicillin-resistant coagulase-negative staphylococcal infections, in 29 % (two/seven) of methicillin-sensitive S. aureus infections and in 75 % (three/four) of infections due to streptococci. The literature review focused on implant preserving approaches yielded 599 cases with an overall success rate of 47 % (284/599) and significantly more remissions in streptococcal vs staphylococcal knee PJIs (43/54 vs 144/324; p < 0.01, odds ratio 4.9, 95 % confidence interval 2.4-10.9). CONCLUSIONS: In addition to established indications for explantation such as implant loosening, sinus tract or methicillin resistance, the decision for debridement and retention of knee PJIs should also depend on the pathogen. Implant preservation is futile with methicillin-resistant staphylococci, but seems to be a valid option for streptococcal PJIs.
Authors: J Cobo; L Garcia San Miguel; G Euba; D Rodríguez; J M García-Lechuz; M Riera; L Falgueras; J Palomino; N Benito; M D del Toro; C Pigrau; J Ariza Journal: Clin Microbiol Infect Date: 2010-07-30 Impact factor: 8.067
Authors: M Mashfiqul A Siddiqui; Ngai Nung Lo; Shaifuzain Ab Rahman; Pak Lin Chin; Shi-Lu Chia; Seng Jin Yeo Journal: J Arthroplasty Date: 2012-06-06 Impact factor: 4.757
Authors: C E Marculescu; E F Berbari; A D Hanssen; J M Steckelberg; S W Harmsen; J N Mandrekar; D R Osmon Journal: Clin Infect Dis Date: 2006-01-05 Impact factor: 9.079
Authors: José Barberán; Lorenzo Aguilar; Guillermo Carroquino; María-José Giménez; Beatriz Sánchez; David Martínez; José Prieto Journal: Am J Med Date: 2006-11 Impact factor: 4.965
Authors: Thomas Bradbury; Thomas K Fehring; Michael Taunton; Arlen Hanssen; Khalid Azzam; Javad Parvizi; Susan M Odum Journal: J Arthroplasty Date: 2009-06-24 Impact factor: 4.757
Authors: I Byren; P Bejon; B L Atkins; B Angus; S Masters; P McLardy-Smith; R Gundle; A Berendt Journal: J Antimicrob Chemother Date: 2009-03-31 Impact factor: 5.790
Authors: Dante P Melendez; Kerryl E Greenwood-Quaintance; Elie F Berbari; Douglas R Osmon; Jayawant N Mandrekar; Arlen D Hanssen; Robin Patel Journal: J Clin Microbiol Date: 2015-11-04 Impact factor: 5.948
Authors: Michael Betz; Sophie Abrassart; Pierre Vaudaux; Ergys Gjika; Maximilian Schindler; Julien Billières; Besa Zenelaj; Domizio Suvà; Robin Peter; Ilker Uçkay Journal: Int Orthop Date: 2014-09-04 Impact factor: 3.075